Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-RI0184 | Human P2RX2/P2RX3 Stable Cell Line-HEK293 | Inquiry |
| CSC-RI0186 | Human P2RX3 Stable Cell Line-HEK293 | Inquiry |
| CSC-DC011199 | Panoply™ Human P2RX3 Knockdown Stable Cell Line | Inquiry |
| CSC-SC011199 | Panoply™ Human P2RX3 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD11706Z | Human P2RX3 adenoviral particles | Inquiry |
| LV20819L | human P2RX3 (NM_002559) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH369468 | shRNA set against Mouse P2RX3 (NM_145526.2) | Inquiry |
| SHR084822 | shRNA set against Mouse P2rx3(NM_145526.2) | Inquiry |
| SHH369464 | shRNA set against Human P2RX3 (NM_002559.3) | Inquiry |
| SHH369472 | shRNA set against Rat P2RX3 (NM_031075.2) | Inquiry |
| SHR063006 | shRNA set against Rat Olr40_predicted(NM_001000127.1) | Inquiry |
| SHW015047 | shRNA set against Danio rerio P2RX3A (NM_131623) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| OE-PNDC000270 | Human P2RX3 Nanodisc | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| MiUTR1M-08835 | P2RX3 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-03672 | P2RX3 miRNA 3'UTR clone | Inquiry |
| CDCB176522 | Danio rerio P2RX3A ORF Clone (NM_131623) | Inquiry |
| CDCB188804 | Rabbit P2RX3 ORF clone (XM_002709156.2) | Inquiry |
| CDCH016050 | Human P2RX3 ORF clone(NM_002559.3) | Inquiry |
| CDCL145277 | Mouse P2rx3 ORF clone (NM_145526.2) | Inquiry |
| CDCR379569 | Rat P2rx3 ORF Clone(NM_031075.2) | Inquiry |
P2RX3 gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel and may transduce ATP-evoked nociceptor activation. Mouse studies suggest that this receptor is important for peripheral pain responses, and also participates in pathways controlling urinary bladder volume reflexes. The development of selective antagonists for this receptor may have a therapeutic potential in pain relief and the treatment of disorders of urine storage.
A common and burdensome symptom in children of inflammatory bowel disease (IBD) is abdominal pain, which is related to the decline of quality of life. Clinical observation shows that the severity of inflammation is often inconsistent with the degree of abdominal pain, and the pain will continue even if the inflammation is fully treated. These observations indicate that except for inflammation, other mechanisms may mediate pain experience. Victoria et al. collected the clinical data from 29 subjects, including the data from multiple children who were newly diagnosed with IBD. As their analysis showed, pain burden can not be predicted by age, sex, and the degree of rectal inflammation, it is worth noting that the pain burden can be only reflected by the P2rX3 expression from rectal biopsy, which explains approximately 20% of the pain burden variance in the participated patient. Expression of other purinergic receptors, such as P2rX4, P2rX7, and P2rY1, exhibited no obvious relation to pain burden.
Traumatic brain injury (TBI) has emerged as a serious public health problem that is the main cause of severe post-traumatic disability. A large number of studies have shown that differentially expressed genes (DEGs) of neural signaling pathways are closely related to brain injury. Huang et al. explored the gene expression related to neuronal survival in the hippocampus by applying a real-time quantitative polymerase chain reaction. They found the upregulation of gene P2RX3 in rats subjected to TBI based on the Western blot and axon growth assay, and the neurite growth promotion of NG108 cells will happen due to the gene overexpression of P2RX3. All these results demonstrated that P2rx3 and other signaling pathways play a pivotal role in TBI.
Praja2 (Pja2) is a member of the animal mammalian ring E3 ubiquitin ligase family. It is reported that it not only participates in many types of cancers but also participates in neurological diseases. However, its genetic mechanism in the nervous system is unclear. In order to study the cellular and molecular functions of Pja2 in neuronal cells of mouse hippocampal, Gong et al. tested the regulatory effects of Pja2 on three Alzheimer's disease (AD) genes and cell proliferation by using the HT-22 cells treated with function increase and function loss operation of Pja2. They revealed the regulatory mechanism of the Pja2 gene in the nervous system. Their results suggest that the P2RX3/P2RX7 axis mediated the regulatory function of neuronal cells in mouse hippocampal. The expression of the AD marker gene was inhibited by Pja2, but the axon growth and cell proliferation were promoted by Pja2. In a word, Gong et al. demonstrated that HT-22 cell development and AD marker genes expression was regulated by the inhibition of P2RX3 expression and the promotion of P2RX7 expression.
Figure 1. The illustration of significant genes expressed in the calcium signaling pathway (Gong et al., 2020).
References: